U.S. pharma huge copyright scrapped two experimental weight loss products past yr—a the moment-daily pill, lotiglipron, because of elevated liver enzymes in addition to a two times-daily pill, danuglipron, due to sturdy Negative effects—but CEO Albert Bourla has explained the company